Metadoro
Markets
Stocks
ASND - Ascendis Pharma A/S (NASDAQ)

ASND

Ascendis Pharma A/S (NASDAQ)

Trading schedule (UTC) -

Open Now Closed Now

Closes on Opening on at

Sell

Buy

Open

High

Low

Day’s range

52wk range

Short swap -0.35

Sell

Long swap -0.35

Buy

Min spread

0.01

Avg spread

Current spread

We don't have analytics for this instrument yet. You can contribute!

Please log in and be the first author to write an article about this instrument!

Ascendis Pharma A/S (NASDAQ)

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company also develops TransCon Growth Hormone for treating pediatric GHD, adult GHD, and turner syndrome; TransCon Parathyroid Hormone for adult patients with hypoparathyroidism; and TransCon C-type natriuretic peptide for achondroplasia. In addition, it is developing TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/" for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

Details

Account Type

CFD Trading: MetaTrader 5

Investing: Web

Commission 0.1 %

Trading schedule (UTC)

Open Now Closed Now Closes on Opening on at

This shows the opening hours in your local time zone (UTC)

Ticker	ASND
Contract value	100 shares
Maximum leverage	1:5

Swaps history

Date	Short Swap (%)	Long Swap (%)
No data

Minimum transaction volume	0.01 lot
Maximum transaction volume	100 lots
Hedging margin	50%

Previous ASML ASML Holding NV (NASDAQ)

Next ASPS Altisource Portfolio Solutions S.A. (NASDAQ)

Investing for everyone

Open an account and start investing with Metadoro now. Invite friends and get rewarded for their active trading. You can learn more about the affiliate program in your personal account.

Open account

The Metadoro brand and the domain "metadoro.com" are managed by RHC Investments, a company incorporated and registered under the laws of Mauritius, with company number 138336 C1/GBL, having its address at 3 EMERALD PARK, TRIANON, QUATRE BORNES, 72257, Mauritius. The Company is authorised and regulated by the Financial Services Authority in Mauritius (“FSA”) under license number C115015381.

Risk Disclosure: Contracts for Difference (CFDs) are complex instruments, CFDs carry a high level of risk of rapid loss of funds due to the use of leverage. You should carefully consider whether you understand the principle of working with CFD instruments and whether you are ready for the high risk of losing your invested capital.

All trademarks, logos and brand names are the property of their respective owners. The names of all companies, products and services used on this website are for identification purposes only. The use of these names, trademarks and brands does not imply endorsement.

Information on this site is not directed at residents in any country or jurisdiction where such distribution or use would be contrary to local law or regulation. Please refer to AML/KYC policy for more information.